AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 27 filers reported holding AQUINOX PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $8,000 | -38.5% | 3,286 | -32.6% | 0.00% | 0.0% |
Q1 2019 | $13,000 | +44.4% | 4,875 | +17.6% | 0.00% | 0.0% |
Q4 2018 | $9,000 | +125.0% | 4,145 | +210.7% | 0.00% | – |
Q2 2018 | $4,000 | -63.6% | 1,334 | +40.0% | 0.00% | -100.0% |
Q4 2017 | $11,000 | +175.0% | 953 | +217.7% | 0.00% | – |
Q2 2017 | $4,000 | -75.0% | 300 | -67.7% | 0.00% | -100.0% |
Q1 2017 | $16,000 | -38.5% | 929 | -41.6% | 0.00% | -33.3% |
Q4 2016 | $26,000 | -78.7% | 1,591 | -82.6% | 0.00% | -75.0% |
Q3 2016 | $122,000 | – | 9,121 | +227925.0% | 0.01% | – |
Q2 2016 | $0 | -100.0% | 4 | -99.8% | 0.00% | -100.0% |
Q1 2016 | $21,000 | -60.4% | 2,455 | -34.2% | 0.00% | -40.0% |
Q3 2015 | $53,000 | +783.3% | 3,729 | +346.6% | 0.01% | +400.0% |
Q2 2015 | $6,000 | 0.0% | 835 | +6.1% | 0.00% | 0.0% |
Q1 2015 | $6,000 | -25.0% | 787 | -24.6% | 0.00% | 0.0% |
Q4 2014 | $8,000 | -38.5% | 1,044 | -48.2% | 0.00% | 0.0% |
Q3 2014 | $13,000 | +44.4% | 2,017 | +101.5% | 0.00% | 0.0% |
Q2 2014 | $9,000 | – | 1,001 | – | 0.00% | – |
Q1 2014 | $0 | – | 0 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 400,900 | $1,062,000 | 0.78% |
EMORY UNIVERSITY | 209,207 | $554,000 | 0.37% |
EcoR1 Capital, LLC | 1,150,000 | $3,048,000 | 0.29% |
Baker Brothers Advisors | 10,934,154 | $28,976,000 | 0.22% |
DLD Asset Management, LP | 763,100 | $2,030,000 | 0.15% |
UNIVERSITY OF NOTRE DAME DU LAC | 214,759 | $569,000 | 0.11% |
Kalos Management, Inc. | 15,850 | $226,000 | 0.10% |
SPHERA FUNDS MANAGEMENT LTD. | 257,613 | $683,000 | 0.09% |
DLD Asset Management, LP | 379,900 | $1,007,000 | 0.08% |
DLD Asset Management, LP | 379,300 | $1,009,000 | 0.08% |